Skip to main content
Clinical Trials/IRCT20211219053451N1
IRCT20211219053451N1
Not yet recruiting
Phase 1

A clinical trial to compare the effectiveness of the granulocyte colony-stimulating factor with standard treatment in non-M3 acute myelogenous leukemia patients

Mashhad University of Medical Sciences0 sites80 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
on-M3 acute myelogenous leukemia patients.
Sponsor
Mashhad University of Medical Sciences
Enrollment
80
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Non\-M3 acute myelogenous leukemia patients have not received treatment
  • Aged between 18 and 70 years

Exclusion Criteria

  • Secondary acute myeloid leukemia patients
  • Pregnant women with leukemia
  • Patients with other malignancies
  • Having cardiovascular disease
  • Patients with Anaphylactic shock

Outcomes

Primary Outcomes

Not specified

Similar Trials